Cargando…
Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause
OBJECTIVE: Vasomotor symptoms affect 60-80% of women during the menopausal transition. Anxiety, depression, and anxiety sensitivity can have an important role in the distressful experience of vasomotor symptoms. Our aim was to evaluate the prevalence and association of vasomotor and negative affect...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Psiquiatria
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136388/ https://www.ncbi.nlm.nih.gov/pubmed/33053044 http://dx.doi.org/10.1590/1516-4446-2020-0871 |
_version_ | 1783695433488400384 |
---|---|
author | Jaeger, Marianna de B. Miná, Camila S. Alves, Sofia Schuh, Gabriela J. Wender, Maria C. Manfro, Gisele G. |
author_facet | Jaeger, Marianna de B. Miná, Camila S. Alves, Sofia Schuh, Gabriela J. Wender, Maria C. Manfro, Gisele G. |
author_sort | Jaeger, Marianna de B. |
collection | PubMed |
description | OBJECTIVE: Vasomotor symptoms affect 60-80% of women during the menopausal transition. Anxiety, depression, and anxiety sensitivity can have an important role in the distressful experience of vasomotor symptoms. Our aim was to evaluate the prevalence and association of vasomotor and negative affect symptoms. METHODS: A cross-sectional study was conducted with 89 perimenopausal women aged 45-55 years. Broad psychiatric and clinical evaluations were carried out. The primary outcome was the vasomotor symptom problem rating and the main study factor was anxiety sensitivity. Linear regression analyses were conducted to examine the associations between the study factors and the primary outcome, and a multiple regression model was created to assess which variables were independently associated with vasomotor symptom problem rating. RESULTS: The prevalence of anxiety, depression, and vasomotor symptoms were 58, 62, and 73%, respectively. Negative affect symptoms were positively associated with vasomotor symptom problem rating. The association of anxiety sensitivity and vasomotor symptom problem rating remained significant after controlling for perimenopausal stage, thyrotropin, follicle-stimulating hormone levels, and psychotropic medication use (β = 0.314, p = 0.002). CONCLUSION: A better understanding of the experience of vasomotor symptoms is needed, especially the role of negative affect symptoms and anxiety sensitivity. New strategies focusing on related thoughts and behaviors could improve the quality of life of perimenopausal women. |
format | Online Article Text |
id | pubmed-8136388 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Associação Brasileira de Psiquiatria |
record_format | MEDLINE/PubMed |
spelling | pubmed-81363882021-05-26 Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause Jaeger, Marianna de B. Miná, Camila S. Alves, Sofia Schuh, Gabriela J. Wender, Maria C. Manfro, Gisele G. Braz J Psychiatry Original Article OBJECTIVE: Vasomotor symptoms affect 60-80% of women during the menopausal transition. Anxiety, depression, and anxiety sensitivity can have an important role in the distressful experience of vasomotor symptoms. Our aim was to evaluate the prevalence and association of vasomotor and negative affect symptoms. METHODS: A cross-sectional study was conducted with 89 perimenopausal women aged 45-55 years. Broad psychiatric and clinical evaluations were carried out. The primary outcome was the vasomotor symptom problem rating and the main study factor was anxiety sensitivity. Linear regression analyses were conducted to examine the associations between the study factors and the primary outcome, and a multiple regression model was created to assess which variables were independently associated with vasomotor symptom problem rating. RESULTS: The prevalence of anxiety, depression, and vasomotor symptoms were 58, 62, and 73%, respectively. Negative affect symptoms were positively associated with vasomotor symptom problem rating. The association of anxiety sensitivity and vasomotor symptom problem rating remained significant after controlling for perimenopausal stage, thyrotropin, follicle-stimulating hormone levels, and psychotropic medication use (β = 0.314, p = 0.002). CONCLUSION: A better understanding of the experience of vasomotor symptoms is needed, especially the role of negative affect symptoms and anxiety sensitivity. New strategies focusing on related thoughts and behaviors could improve the quality of life of perimenopausal women. Associação Brasileira de Psiquiatria 2020-10-09 /pmc/articles/PMC8136388/ /pubmed/33053044 http://dx.doi.org/10.1590/1516-4446-2020-0871 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Jaeger, Marianna de B. Miná, Camila S. Alves, Sofia Schuh, Gabriela J. Wender, Maria C. Manfro, Gisele G. Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause |
title | Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause |
title_full | Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause |
title_fullStr | Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause |
title_full_unstemmed | Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause |
title_short | Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause |
title_sort | negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136388/ https://www.ncbi.nlm.nih.gov/pubmed/33053044 http://dx.doi.org/10.1590/1516-4446-2020-0871 |
work_keys_str_mv | AT jaegermariannadeb negativeaffectsymptomsanxietysensitivityandvasomotorsymptomsduringperimenopause AT minacamilas negativeaffectsymptomsanxietysensitivityandvasomotorsymptomsduringperimenopause AT alvessofia negativeaffectsymptomsanxietysensitivityandvasomotorsymptomsduringperimenopause AT schuhgabrielaj negativeaffectsymptomsanxietysensitivityandvasomotorsymptomsduringperimenopause AT wendermariac negativeaffectsymptomsanxietysensitivityandvasomotorsymptomsduringperimenopause AT manfrogiseleg negativeaffectsymptomsanxietysensitivityandvasomotorsymptomsduringperimenopause |